Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keeping Track: Oncology Filings Galore In Run-Up To ASCO Meeting

Executive Summary

The latest cancer drug development news and highlights from our FDA Performance Tracker.

Advertisement

Related Content

Keeping Track: Oncology Announcements, Priority Review Vouchers Continue To Pile Up
Oncology: Tissue-Agnostic Indications Advance Under US FDA's Breakthrough Umbrella
Biomarker-Led Claim Is Small Step For Merck's Keytruda, Giant Leap For Cancer Indications
Kalydeco Expands Indication Without Clinical Data; Keytruda Is Latest Bladder Cancer Approval
CAR-T Cancer Drugs Front And Center At ARM Investor Day
Keeping Track: Immuno-Oncology Racks Up More Approvals; Bar Still Too High For Advair Generics
Too Sick For CAR-T? Kite Reports Cerebral Edema Death
Keeping Track: US FDA Approvals Binge Continues With Dupixent, Ocrevus And Zejula; Two CAR-T Are Under Review
Keeping Track: US FDA Files Another Pfizer Cancer Biologic And TMC's New Antibiotic

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120750

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel